ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
5,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
9,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
9,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,6,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
9,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10,6,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
10,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,6,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
11,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
12,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
12,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
13,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
13,2,Oesophageal obstruction,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
14,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
14,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
15,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
16,2,Headache,Headaches NEC,Headaches,Nerv,N
16,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,4,Meningeal disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
16,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
16,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
17,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
18,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
19,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
19,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
20,1,Nail avulsion,Skin injuries NEC,Injuries NEC,Inj&P,N
20,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
20,3,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
20,4,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
21,1,Abnormal clotting factor,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
21,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
21,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
22,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
22,4,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
22,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
23,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
24,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
25,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,2,Blood alkaline phosphatase decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
26,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
28,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
28,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
29,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
29,4,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
29,5,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
29,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
29,7,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
29,8,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
29,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
29,14,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
29,15,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
29,16,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
29,17,Headache,Headaches NEC,Headaches,Nerv,N
29,18,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
29,19,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
29,20,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
29,21,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
29,22,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,23,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
29,24,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
29,25,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
29,26,Myopathy,Myopathies,Muscle disorders,Musc,N
29,27,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
29,28,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,29,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
29,30,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
29,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,33,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
29,34,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,35,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,36,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,37,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
29,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
30,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
30,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
30,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
30,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,6,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
30,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,11,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
30,12,Headache,Headaches NEC,Headaches,Nerv,N
30,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,14,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
30,15,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
30,16,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
30,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,18,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
30,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
30,20,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
30,21,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
30,22,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
30,23,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,24,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
30,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
31,4,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
31,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
33,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
33,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
34,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
34,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
34,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
36,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
36,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
38,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
38,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
39,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
40,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
41,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
41,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
41,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
42,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
43,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
43,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
43,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
43,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,12,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
43,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,15,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
45,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
46,2,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,Y
47,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
47,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
47,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
47,4,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
48,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
48,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
50,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
50,3,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
50,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
50,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
50,6,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
50,7,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
51,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
52,2,Chest wall mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
52,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
52,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
52,6,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,2,Metastases to skin,Metastases to specified sites,Metastases,Neopl,N
53,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Acne,Acnes,Skin appendage conditions,Skin,N
54,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
54,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
54,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
54,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
54,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,9,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
54,10,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,11,Headache,Headaches NEC,Headaches,Nerv,N
54,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,13,Inflammatory pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
54,15,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
54,16,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
54,17,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
54,19,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,20,Plantar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,22,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
54,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
55,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
59,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
59,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,3,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
60,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
61,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
61,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
61,3,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
62,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
63,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
63,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
65,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Gallbladder cancer stage IV,Gallbladder neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
65,3,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
65,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
